Gynecology Book


Vulvar Lichen Planus

Aka: Vulvar Lichen Planus, Lichen Planus of the Vulva, Vulvovaginal-Gingival Syndrome
  1. See Also
    1. Lichen Planus
  2. Definition
    1. Autoimmune inflammatory condition that affects keratinized areas including vulva
  3. Epidemiology
    1. Affects patients between ages 30 to 60 years
    2. Much less common than Vulvar Lichen Sclerosus as a cause for Vulvar Dermatitis
  4. Types
    1. Erosive Lichen Planus (most common variant)
      1. Glassy appearing white Papules and Plaques
      2. Progression to ulcers and erosions with altered Vulvar Anatomy
      3. Vagina involved in 70% of cases (vagina not involved in Lichen Sclerosus)
        1. Vaginitis characterized by friable, tissue with adhesions and serous discharge
      4. May concurrently involve Vulvovaginal-Gingival Syndrome
    2. Papulosquamous Lichen Planus
      1. Poorly demarcated pink opaque Papules
    3. Hypertrophic Lichen Planus
      1. Perineum and perianal hyperkeratotic lesions
      2. May present as Squamous Cell Carcinoma
  5. Symptoms
    1. Vulvar Pruritus or burning
    2. Postcoital bleeding
    3. Dyspareunia
  6. Signs
    1. See types above
    2. Speculum exam is very uncomfortable in erosive Lichen Planus due to associated Vaginitis
  7. Labs: Erosive Lichen Planus
    1. Punch Biopsy of erosion borders
    2. KOH and wet prep to evaluate for fungal and Bacterial causes of Vaginitis
  8. Differential Diagnosis: Erosive Lichen Planus
    1. Lichen Sclerosus
    2. Pemphigoid
    3. Pemphigous vulgaris
    4. Behcet's Syndrome
    5. Vaginitis
    6. Drug Reaction
  9. Management
    1. Hydrocortisone suppositories for vaginal lesions
    2. Topical Corticosteroid for vulvar lesions (or applied on vaginal dilator for erosive Vaginitis)
      1. Choice of strength depends on severity
        1. Level 1: Clobetasol Propionate 0.05% ointment (ultra-potent bid in severe cases)
        2. Level 2: Betamethasone Dipropionate 0.05% ointment
        3. Level 3: Betamethasone Dipropionate 0.05% cream
        4. Level 4: Triamcinolone Acetonide 0.1% ointment (medium potency qhs in mild cases)
      2. Taper steroid on resolution of active lesions
    3. Systemic Corticosteroids
      1. Indicated in cases refractory to Topical Corticosteroids
      2. Prednisone 40 to 60 mg orally daily for 2-4 weeks
  10. References
    1. Goldstein (2005) Clin Obstet Gynecol 48:818-23 [PubMed]
    2. O'Connell (2008) Am Fam Physician 77: 321-30 [PubMed]

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree